Who we are

PharmaLex China is the Chinese office of the PharmaLex Group. PharmaLex China acts as a liaison office to set up cooperations and extend exchange with the PharmaLex Group and our local Chinese partner company.

  • Through the liaison office PharmaLex China covers all services required by health agencies worldwide and partners with customers from China to provide solutions for their international needs.
  • We help customers in China to access mature markets like the US and Europe.
  • Our Chinese partner is able to understand local nuances of the regulatory framework for international clients interested in the Chinese market.
  • Our goal is to offer enhanced regulatory support to customers throughout China’s pharma market.

Local Contact

  • Stefanie Fasshauer
    Manager, Regulatory Affairs PharmaLex China
    Unit 2508A / 25 F
    Bank of America Tower
    12 Harcourt Road Central
    Hong Kong
    +852 9833 5953

What our clients say about us

We are working with a number of large pharma companies and are looking to create a consortium of partners to collect feedback on expertise, availability and outcomes. If you would be interested in joining our consortium, please contact us on contact@pharmalex.com.

  • I just wanted to let you know that the recent EU Codes webinar was excellent. Rina presented a very complex and grey topic in the most clear and digestible manner – a sign of a true expert. The questions in the Q&A were sometimes a little ambiguous but Rina gave clear and relevant answers that provided real clarity.

    Richard Blackwell
    Medical Team Leader, Multi Tumor Franchise Roche Products Ltd
  • Hard working and there when you need them

    Europe based large biotech
    Regulatory Manager
  • We really appreciate your responsiveness and availability during our previous exchanges and it is what we are waiting for from our partner.

    Small Medium Sized Company, UK
    Head of Regulatory Affairs
  • Our project team were very impressed with the quality of the research and the reports that you sent through. We didn’t need any convincing that your recommendations should be followed. It showed PharmaLex in a very positive light, and the Project Team are keen to work with you again.

    Leading European Specialist Pharma Company
    Head of Medical Writing and Publications